Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
3.880
-0.350 (-8.27%)
May 6, 2025, 12:10 PM EDT - Market open
Solid Biosciences Employees
Solid Biosciences had 100 employees as of December 31, 2024. The number of employees increased by 12 or 13.64% compared to the previous year.
Employees
100
Change (1Y)
12
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,246,970
Market Cap
300.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
SLDB News
- 4 days ago - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 days ago - Solid Biosciences to Participate at The Citizens Life Sciences Conference - GlobeNewsWire
- 7 days ago - Solid Biosciences to Present at the American Society of Gene and Cell Therapy's 28th Annual Meeting - GlobeNewsWire
- 27 days ago - Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space - Seeking Alpha
- 5 weeks ago - Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul - New York Post
- 7 weeks ago - Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - GlobeNewsWire
- 2 months ago - Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewsWire